The National Childhood Cancer Registry of Chile: a population-based study of childhood cancer and insights for low- and middle-income countries.
Chile's comprehensive childhood cancer registry shows survival improving from 71% to 81%, validating an inclusive tracking model for low-resource settings.
Chilean national childhood cancer registry (8821 cases, 2007-2023) demonstrates improving 5-year survival (71.4% to 80.5%) and declining mortality, with leukemia (58.6/million) and lymphoma (12.7/million) as the dominant hematologic malignancies; provides first LMIC 100%-coverage IARC-validated registry model. This record was retained from the prior triage attempt for PubMed pipeline handoff.
What the study was
- Study design
- population_registry_study
- Category
- hematologic_malignancies
- Maturity
- Validated
- Journal
- Lancet Regional Health Americas
Why it surfaced
Lancet journal; first IARC-validated 100%-coverage LMIC childhood cancer registry; leukemia/lymphoma dominate; improving survival trends relevant to T1 watchlist; valuable reference for global hematologic malignancy epidemiology.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.